Solicitation, total small business set-aside
Purchase of a High Throughput Short Read Next Generation Sequencing System
75F40124Q00104
Food and Drug Administration, FDA Center for Drug Evaluation and Research. Biological Product (except Diagnostic) Manufacturing.
Awarded
$219,300.00 obligated so far on USAspending
Description
As published on SAM.gov.
Purchase of a High Throughput Short Read Next Generation Sequencing System Questions Due by 3PM EST 03/15/2024 Proposals Due by 2:30PM EST 03/28/2024
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Illumina, Inc.
- UEI
- KMW3CRWNAAF3
- CAGE
- 1WCS2
- Vendor location
- San Diego, CA
- Contract
- 75F40124P00121, purchase order
- Obligated
- $219,300.00
- Actions
- 1 between April 4, 2024 and April 4, 2024
- Competition
- Competed Under SAP, 1 offer received
- Set-aside reported
- No Set Aside Used.
- Described as
- Nextseq 2000 Sequencing System
- Match
- solicitation number 75F40124Q00104 equals the FPDS solicitation identifier; same sub-agency 7524 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
February 28, 2024
Solicitation
Due March 28, 2024 at 2:30 PM EDT. SAM.gov, notice 44a8b097f4d540bb98f73884ae4e2971
Points of contact
- Sheila Brownsheila.brown1@fda.hhs.gov